jackytrensius
reacted to
- Moomoo Recognized for the 3rd Straight Year at the Benzinga Global Fintech Awards*
The intuitive investment and trading platform moomoo, today announced it has won the Best Day Trading Software award at the 2023 Benzinga Global FinTech Awards Ceremony. For the third year in a row, moomoo was named a Benzinga Fintech award finalist in various categories.
This year, moomoo was nominated in seven categories: B...
The intuitive investment and trading platform moomoo, today announced it has won the Best Day Trading Software award at the 2023 Benzinga Global FinTech Awards Ceremony. For the third year in a row, moomoo was named a Benzinga Fintech award finalist in various categories.
This year, moomoo was nominated in seven categories: B...
93
7
jackytrensius
liked
Hello, mooers! As 2023 winds down, it's amazing to look back at the wealth of knowledge and insights we've shared in our community. Each conversation has been a learning opportunity, showcasing the power of our collective wisdom.![]()
This sparked a brilliant idea: Why don't our community members get together for a live online chat? Imagine a cozy gathering where we recap the year 2023 and peer into what 2024 might hold. For this exciting event, we're o...
This sparked a brilliant idea: Why don't our community members get together for a live online chat? Imagine a cozy gathering where we recap the year 2023 and peer into what 2024 might hold. For this exciting event, we're o...
110
79
jackytrensius
reacted to and voted
$Vivos Therapeutics (VVOS.US)$ Stock is rocketing higher on Wednesday after the U.S. Food and Drug Administration (FDA) granted approval to its sleep apnea treatment device.
According to a press release from the company, vivos therapeutics has been granted 510(k) clearance from the FDA for its removable CARE oral applications. That covers its DNA oral appliance, mRNA oral appliance and its mmRNA oral appliance.
Vivos points out that this is the first approval ...
According to a press release from the company, vivos therapeutics has been granted 510(k) clearance from the FDA for its removable CARE oral applications. That covers its DNA oral appliance, mRNA oral appliance and its mmRNA oral appliance.
Vivos points out that this is the first approval ...
Translated
5
jackytrensius
liked
The U.S. economy has steady growth during the Q2 2023, matching experts' expectations. For what’s important, the gross domestic product (GDP) saw a growth of 2.1% in this period, while the first quarter was revised to reflect a 2.2% growth rate, up from the initial 2.0% report.
Historical GDP data was also updated due to new information and improved methods. Interestingly, GDP for the early months of 2020, 2021, and 2022 was lowered as consumers spending was less than...
Historical GDP data was also updated due to new information and improved methods. Interestingly, GDP for the early months of 2020, 2021, and 2022 was lowered as consumers spending was less than...
50
jackytrensius
liked
$Tesla (TSLA.US)$ recently released its vehicle production and delivery data for the third quarter of 2023:
Total deliveries for Q3 2023: 435,059 vehicles.
Total production for Q3 2023: 430,488 vehicles.
In contrast, during the previous quarter, Tesla delivered 466,140 vehicles and produced 479,700. In the same period in 2022, they had 343,830 deliveries from a production of 365,923 vehicles.
This result not only missed Wall Street's proj...
Total deliveries for Q3 2023: 435,059 vehicles.
Total production for Q3 2023: 430,488 vehicles.
In contrast, during the previous quarter, Tesla delivered 466,140 vehicles and produced 479,700. In the same period in 2022, they had 343,830 deliveries from a production of 365,923 vehicles.
This result not only missed Wall Street's proj...
64
25
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)